Influenza viruses impose a constant threat to vertebrates susceptible to this family of viruses. We have developed a new tool to study virus-host interactions that play key roles in viral replication and to help identify novel anti-influenza drug targets. Via the UAS/Gal4 system we ectopically expressed the influenza virus M2 gene in Drosophila melanogaster and generated dose-sensitive phenotypes in the eye and wing. We have confirmed that the M2 proton channel is properly targeted to cell membranes in Drosophila tissues and functions as a proton channel by altering intracellular pH. As part of the efficacy for potential anti-influenza drug screens, we have also demonstrated that the anti-influenza drug amantadine, which targets the M2 proton channel, suppressed the UAS-M2 mutant phenotype when fed to larvae. In a candidate gene screen we identified mutations in components of the vacuolar V 1 V 0 ATPase that modify the UAS-M2 phenotype. Importantly, in this study we demonstrate that Drosophila genetic interactions translate directly to physiological requirements of the influenza A virus for these components in mammalian cells. Overexpressing specific V 1 subunits altered the replication capacity of influenza virus in cell culture, and suggests that drugs targeting the enzyme complex via these subunits may be useful in anti-influenza drug therapies.
INTRODUCTION
Influenza viruses, of the family Orthomyxoviridae, infect vertebrates and are the causative agents of the respiratory disease influenza. Influenza virus can infect a wide variety of animals and can thus spread from population to population. The outcomes of an influenza virus outbreak can be catastrophic, as evidenced by the 1918 Spanish Flu which caused approximately 50 million deaths worldwide. (PALESE and SHAW 2007; WRIGHT et al. 2007) Influenza viruses infect and replicate in cells of the upper and lower respiratory tract. Successful entry of the virus into a cell requires two influenza virus proteins: hemagglutinin (HA), which binds to sialic acids on the surface of cells for attachment, and matrix protein 2 (M2), which lowers the pH inside the virion, allowing for viral uncoating (PALESE and SHAW 2007) . M2 modulates pH due to its proton-transport activity. M2 is a small, type III integral membrane protein that acts as a proton pump (PALESE and SHAW 2007; PINTO and LAMB 2006) . M2 functions as a tetramer and can be found inserted into a variety of membrane systems within the cell, such as the plasma membrane and Golgi. However for the M2 channel to be active, the N-terminal ectodomain of M2 must be located in a compartment with a pH lower than 7.0 (PINTO and LAMB 2006) . In the case of viral uncoating, the influenza virus is imported into the cell within an endocytic vesicle, which contains a lowered pH. M2 becomes active and protons flow via the channel into the virion core, allowing the viral genome and its associated proteins to disassociate. (PALESE and SHAW 2007) As M2 and HA are both membrane proteins, they are processed and targeted to the plasma membrane through the secretory pathway. HA is pH sensitive, and changes conformation at a lowered pH. This change in HA conformation allows for the fusion of the viral and vesicle membranes (PALESE and SHAW 2007) . When traveling through the secretory pathway, the ectodomain of M2 is located within the Golgi lumen, which has a lowered pH, and M2 can become active and pump protons out of the Golgi, raising the pH of the Golgi lumen. For strains of influenza virus with acid-sensitive HAs (including H5 and H7), this activity prevents HA from prematurely adopting a lower-pH conformation. (PALESE and SHAW 2007) Currently there are four commonly used anti-influenza virus drugs available: amantadine and rimantadine, which target the influenza virus M2 protein, and zanamivir and oseltamivir, which target the influenza viral protein neuraminidase (NA) (PALESE and SHAW 2007) . Unfortunately, these drugs are not always effective against influenza, since they are viral-strain specific. Resistance to amantadine is of particular concern, as many common influenza virus strains are resistant to amantadine (an example found in (LAN et al. 2010) ). Therefore the need for new anti-influenza drugs is paramount, as is the need to develop new and novel strategies to develop anti-viral drugs as a whole. In this study we develop a genetic system that allows for the identification of host genes that modulate influenza virus M2 activity. The identification of host genes involved with M2 activity will not only aid in the understanding of how cellular machinery affects M2's role in the intracellular propagation of the influenza virus, but also provide new targets for anti-influenza drug therapy as well.
The Drosophila model system has been previously used to study a variety of human diseases including neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, neuromuscular diseases, mitochondrial diseases, cancer, diabetes, and prions, to name a few (BOTELLA et al. 2009; CHAN and BONINI 2000; FORTINI and BONINI 2000; HAFEN 2004; HIRTH 2010; IIJIMA-ANDO and IIJIMA ; LASKO 2002; LLOYD and TAYLOR ; LU and VOGEL 2009; REA et al. 2010; RINCON-LIMAS et al. 2010; VIDAL and CAGAN 2006) . In addition, a few human viruses including Epstein-Barr virus, cytomegalovirus, and HIV have been studied in transgenic flies (ADAMSON et al. 2005; SPRESSER and CARLSON 2005; STEINBERG et al. 2008) . By expressing the influenza A virus M2 protein in Drosophila melanogaster we have created a new research tool to study the influenza virus, which we call the M2 "Flu Fly." Expression of the influenza virus M2 gene in specific fly tissues resulted in significant and obvious mutant phenotypes. Characterization of the M2 phenotypes within these Drosophila tissues indicated that the M2 protein has correctly localized in these cells and functions properly as a proton channel as well. We have performed a candidate genetic screen to identify genetic modifiers of M2 function, showing that some, but not all, of the subunits of the cellular V 1 V 0 ATPase proton pump act as modifiers of M2-mediated phenotypes. To show the conservation of these genetic interactions, we further demonstrated that alteration of V 1 V 0 ATPase proton pump activity in mammalian cultured cells also affects influenza viral infection and replication within these cells.
We believe that our M2 Fly Fly system is valuable because we can examine the effects of overexpression of a viral gene within an intact organism, at any stage of development or in any tissue. Furthermore, the modification of M2 activity by either a genetic modifier or a drug compound can be easily determined by visually examining adult flies. The screen that we have performed for this work has yielded specific and interesting results.
RT. The DNA and Lipofectamine 2000 dilutions were combined and incubated for 20 min at RT, after which they were added to cells plated in 60 mm plates containing 5 ml DMEM with no serum or additives.
UAS-M2 flies:
The influenza A virus M2 cDNA (from the A/Udorn/72 virus) (ZEBEDEE et al. 1985) was cloned into pCaSpeR 3, an Upstream Activation Sequence (UAS) P element vector which included the mini-white + marker gene. This vector was injected into Drosophila melanogaster w 1118 embryos as previously described (SPRADLING and RUBIN 1982) . These embryos were allowed to develop into adults and mated back to w 1118 flies. In the next generation, the flies which had the P-element vector inserted in their genome were identified by their eye color, which ranged from orange to red. Ten UAS-M2 lines were produced, containing UAS-M2 insertions on either the second or third chromosome. When crossed to the Gal4 drivers (see Fly crosses, below) each line yielded identical mutant phenotypes (all temperature-and dose-sensitive).
UAS-M2 flies may be requested by contacting the corresponding author. Amantadine treatment: GMR-Gal4:UAS-M2/CyO second instar larvae were placed on our regular fly food supplemented with a combination of water and amantadine hydrochloride (Sigma) to total 0, 10, 20, 30, or 40 g/ml amantadine hydrochloride.
Amantadine was added daily for seven days. Flies were kept at 29° for the entire period, up to eclosion. 
RESULTS

Creation
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at 29° caused an even more severe eye phenotype, causing a total loss of eye tissue (data not shown). Furthermore, males were found to have more severe eye phenotypes than females (data not shown).
UAS-M2 expression and M2 proton channel activity in Drosophila tissues:
Within influenza virus-infected cells, the M2 protein would be expected to be localized to membrane systems including the plasma membrane and the endoplasmic reticulum/Golgi apparatus. Since the N-termini of the M2 proton channels would be present in the lumens of intracellular organelles and vesicles, protons would be transferred out of these compartments and into the cytoplasm, leaving the lumens of the intracellular organelles and vesicles more basic than those of uninfected cells.
To examine the M2 protein localization within cells of our Drosophila system, we immunostained larval tissues expressing the M2 protein, in different tissues and under different Gal4 drivers, with an anti-M2 antibody. In third instar eye imaginal discs, UAS-M2 was expressed under the GMR-Gal4 driver in cells posterior to the morphogenetic furrow ( Fig. 3B ). The localization of M2 was found to be apical in relation to nuclei, as was actin (Fig. 3) . We expressed UAS-M2 in the epithelial cells of the larval fat body using the C125-Gal4 driver; in fat body, the M2 protein was targeted to the plasma membrane ( Fig. 4B ). In addition, M2 was found localized to intracellular membrane systems ( Fig. 4B , E, H, K). To examine the intracellular localization of the M2 protein in relation to specific intracellular compartments in the fat body, we compared M2 localization to the localizations of GFP-tagged actin, -Golgi, -clathrin, and -endoplasmic reticulum (ER) (Fig. 4A , D, G, J). M2 clearly co-localized with actin, especially at the plasma membrane (Fig. 4C ). M2 also co-localized with the Golgi, especially at the cell periphery ( Fig. 4F) . Similarly, M2 shared some co-localization with clathrin-GFP ( Fig.   4I ). Clathrin is a vesicle protein coat that is found on vesicles budding from the transGolgi and from the plasma membrane. M2 did not appear to co-localize with the ER to a great extent (Fig. 4L ). M2 localization was also examined in Drosophila salivary glands (Supplemental Fig. S1 ). Interestingly, the localization of M2 in salivary glands was found to be basal instead of apical. This basal membrane localization appeared to colocalize with basal membrane actin (Supplemental Fig. S1 ). Overall, these experiments demonstrated that the M2 protein was targeted to the plasma membrane and to the membranes of intracellular organelles or vesicles, as would be found in mammalian cells.
To determine whether the expressed M2 protein functioned as a proper proton channel within Drosophila tissue, we examined the relative pH of intracellular organelles and vesicles, comparing M2-expressing and control tissues. Since the M2 proton channel transports protons from a region of higher proton concentration to a region of lower proton concentration, thus raising the pH in one compartment and lowering it in another, we predicted that the pH in acidic compartments in cells (for example the Golgi and vesicles) expressing M2 would become higher (more basic) than in the wild-type control, as the M2 channels would transport protons from inside the compartments out into the cytosol.
We determined the relative changes in intracellular pH using two vital dyes, SNARF-1 and BCECF, whose fluorescent properties change in response to changes in intracellular pH (HAN and BURGESS 2010) . SNARF-1 is a fluorescent dye that excites with a light wavelength of 488 nm but whose emission changes according to the pH. In more acidic solutions SNARF-1 fluoresces with an emission peak at around 580 nm, while in more basic solutions the emission peak rises to 640 nm. By determining and comparing the ratios of 640 nm/580 nm emissions between intracellular compartments of wild-type (the C135-Gal4 driver alone) larval fat body and intracellular compartments within fat body tissue expressing M2, we were able to determine changes in relative pH; the higher the ratio number the more basic the pH within the compartments. We observed a significant increase in the 640 nm/580 nm SNARF-1 emission ratios of intracellular compartments in M2-expressing cells, which indicated an increase in the pH within these compartments (Table 1) .
As a complement to these experiments we utilized another vital dye, BCECF, which functions in a slightly different manner. Unlike SNARF-1, BCECF has two excitation wavelengths that are pH-dependent, but emits at a single wavelength of 535
nm. Under acidic conditions, the major excitation wavelength is 440 nm while under more basic conditions the excitation wavelength shifts to 490 nm. By comparing the ratios of 535 nm emission from both excitation wavelengths, we examined the changes in pH within intracellular compartments, in wild-type (the C135-Gal4 driver alone) fat body tissue and M2-expressing fat body tissues. Akin to the SNARF-1 results, we observed a significant increase in the 490 nm/440 nm excitation ratios in the compartments within cells expressing M2, which demonstrated that the pH of intracellular compartments had increased relative to the control (Table 1) . Fig. 4M , N shows the difference in BCECF fluorescence intensity between control and M2-expressing cells. When the cells were exposed to an excitation wavelength of 490 nm the control compartments did not fluoresce (as they were still acidic) (Fig. 4M ) but the M2-expressing compartments did fluoresce (as they had become more basic) (Fig. 4N) .
Amantadine rescues the M2 phenotype: Amantadine is an anti-influenza A virus drug that targets the M2 ion channel. Amantadine plugs the M2 channel and thus prevents proton flow (DUFF et al. 1994 ; WANG et al. 1993 ) . To examine whether amantadine would affect M2 activity in our Drosophila model system, we added amantadine hydrochloride to fly food and fed this to GMR-Gal4:UAS-M2/+ larvae (from 2 nd instar through pupation) kept at 29°. Upon eclosion, adults were scored for a rough eye phenotype. Flies with any form of the rough eye phenotype were scored as "rough."
We found that amantadine was able to revert the UAS-M2 rough eye phenotype, both quantitatively and qualitatively, towards a wild type appearance (Table 2 and Fig. 5 ).
This effect was dose-dependent and exhibited a phenotypic threshold effect: while the lower dose of 10 g/ml yielded minimal changes to the phenotype, 20, 30 and 40 g/ml amantadine restored the phenotype to near wild type (Table 2 and Fig. 5 ). The number of flies with a rough eye phenotype decreased as the amantadine concentration increased, so that with the 40 g/ml concentration only 9% of the flies had the rough eye phenotype shown in Fig. 5 ; the other 91% of flies resulting from this treatment were wild-type in appearance. By demonstrating that an anti-M2 drug works in our fly system, we further validate the study of the influenza virus using our Drosophila model system.
Candidate screen for modifiers of M2 phenotype: Since M2 transfers protons and alters the pH across various membrane systems within a cell, the function (or dysfunction) of endogenous proton pumps in the cell may affect the efficiency in which M2 alters pH. Therefore we performed a candidate gene screen to identify genetic modifiers of the UAS-M2 phenotype. We initially chose to screen mutations in ion transport/pH homeostasis-related genes as they would most likely be able to affect M2 activity. Even though it is known that loss of the V 1 V 0 ATPase pump affects influenza viral infection, we were interested in dissecting this further, by looking at the individual protein subunits and how knocking down each subunit by 50% would affect M2 activity.
To this end, we crossed GMR-Gal4:UAS-M2/+ females to males that harbored deficiencies and mutations in genes that are predicted to encode proteins involved in ion transport and/or pH homeostasis in the cell. Besides the deletions, which would be null alleles, most of the alleles tested contained P element insertions within the coding regions (Flybase.org; Table 3 ). Where documented, many alleles cause a reduction or loss of V 1 V 0 ATPase pump activity and are recessive lethal (ALLAN et al. 2005; DAVIES et al. 1996; DOW 1999; DOW et al. 1997 ) (FlyBase.org). Crosses were maintained at both 22º and 29°. We then scored the progeny for alterations of the UAS-M2 phenotype.
Modifications included slight enhancers, where the eye phenotype was more rough, had areas of black pigmentation, and/or were slightly smaller than UAS-M2/+ eyes. Strong enhancers had very small, narrow eyes that were smooth with no/few ommatidia. Slight suppressors included eyes that had more wild-type appearing ommatidial structure (less rough). Alleles that modified the UAS-M2 phenotype are listed in Table 3 ; all alleles tested are listed in Supplemental Table S1 . We found that mutations in the genes whose proteins encode subunits of the vacuolar V 1 V 0 ATPase were consistent modifiers of the UAS-M2 eye phenotype. Notably, all V 1 subunits had at least one mutant allele that modified the UAS-M2 phenotype, while three of the eleven V 0 subunit mutants modified the UAS-M2 phenotype. The strongest modifiers were vha44, vha55, vha68-1 and vha68-2 (Table 3 and Fig. 6 ). These were concluded to be the best modifiers of the UAS-M2 phenotype because most or all alleles tested for each gene strongly enhanced the UAS-M2 phenotype, and did so at room temperature for at least one allele. These four Fig. 7A-E) . This was confirmed with plaque assays (Fig. 7F ) and had been previously observed in Ochiai et al 1995 , Perez and Carrasco 1994 , and Guinea and Carrasco 1995 (GUINEA and CARRASCO 1995 OCHIAI et al. 1995; PEREZ and CARRASCO 1994) .
Using a second approach, we overexpressed the specific subunits of the V 1 V 0
ATPase that we identified as significant in our genetic screen within cells and examined subsequent viral infection. MDCK cells were transfected with expression vectors for human V 1 A, V 1 B, or V 1 C, along with a vector expressing membrane-localized GFP to track transfected cells. Cells were infected with H1N1 virus 24 hr later, and after 48 hr underwent immunocytochemistry with an anti-HA antibody to detect viral infection and replication levels. We found that overexpression of any of the subunits produced an increase in the number of infected cells, as well as an increase in replication within cells, as judged by HA levels within cells (Figure 8) . Figure 8A -P shows representative cell staining for each of the overexpressed subunits. The number of cells that became infected with influenza virus subsequent to overexpression of any of the subunits increased significantly, along with the level of HA protein within these cells (Fig. 8Q) .
These results were also corroborated by plaque assays, which showed that overexpression of any of the three subunits lead to greater influenza viral infection (Fig. 8R ).
DISCUSSION
The influenza virus has been the root cause for a number of deadly pandemics throughout history. We have developed a Drosophila model to study the genetics of influenza viral/host interactions. Using the UAS/Gal4 system we expressed the influenza A virus M2 gene in a variety of Drosophila tissues and found that M2 maintained both its proper subcellular localization to cellular membranes, and function, as a pH modulator. We established that the localization of M2 within the eye tissue was apical (see Fig. 3 ), which mirrors the localization of M2 within human cells of the respiratory tract (HUGHEY et al. 1992) . Furthermore, in all fly tissues tested, M2 also co-localized with actin at the plasma membrane. Similar observations have been noted in mammalian cells where influenza pre-viral particles (i.e. genomes and envelope proteins) congregate at the plasma membrane, aided by actin microfilaments, for viral particle assembly and budding (NAYAK et al. 2009; SIMPSON-HOLLEY et al. 2002) .
Expression of M2 within specific Drosophila tissues via the bipartite UAS/Gal4 system resulted in specific mutant phenotypes in adult flies. M2 expression in wings via the engrailed-Gal4 (en) driver led to a wing phenotype dominated by the loss of the anterior cross veins; M2 expression in eyes via the Glass-mediated-response-Gal4
(GMR) driver caused the eyes to be smaller and rough. These phenotypes were both temperature-sensitive and dose-dependent, and served as powerful tools for the investigation of the interactions between M2 and host cellular genes.
The localization and function of M2 in Drosophila cells remains unchanged from its activity and localization in mammalian cells. In addition, we demonstrated that the anti-viral drug amantadine suppressed the UAS-M2 mutant phenotype. The results that we have obtained with amantadine suggest that our M2 "Flu Fly" system will also be amenable to performing small molecule drug screens to find inhibitors of M2 activity.
We utilized the dose-and temperature-dependent UAS-M2 eye phenotype to screen for second-site modifiers of the UAS-M2 phenotype. From of collection of 57
candidate genes that encoded components of the V 1 V 0 ATPase or proteins predicted to be involved in the regulation intracellular pH homeostasis, we demonstrated that mutations in the genes encoding for the V 1 V 0 ATPase subunits, especially vha68, vha55, and vha44, yielded strong modifications of the UAS-M2 eye phenotype (see Table 3 ). It is interesting to note that not all V 1 V 0 ATPase subunits tested led to modifications of the UAS-M2 phenotype, suggesting that the strong UAS-M2 modifiers (vha68, vha55, and vha44) play key roles in the regulation and/or assembly of the V 1 V 0 ATPase enzyme complex, in regard to M2 activity, and therefore may serve as especially interesting and specific targets for anti-viral drug design.
The V 1 V 0 ATPase is a proton pump that uses ATP to drive transport of protons against the concentration gradient. This pump regulates pH in a variety of intracellular compartments (JEFFERIES et al. 2008) . For example, in late endosomes, the V 1 V 0 ATPase increases the pH within this compartment to facilitate the hydrolysis of endocytosed molecules ( VAN DYKE 1996) . vha68, vha55, and vha44 encode the Drosophila homologues for the mammalian V 1 A, V 1 B, and V 1 C, subunits respectively. The subunits V 1 A and V 1 B are involved in ATP binding and hydrolysis. When ATP is hydrolyzed, conformational changes in V 1 A drive rotation of the central stalk. This activity drives proton transport. The V 1 C subunit is located between the V 1 and V 0 domains, and can dissociate from the rest of the pump. Since disassembly of the pump regulates pump activity, C appears to play a regulatory role (JEFFERIES et al. 2008) . Reassembly of the pump requires the joining of the V 1 domain, the V 0 domain, and subunit V 1 C. This assembly has been shown to be regulated by glucose concentrations and by the Ras/cAMP/PKA pathway (BOND and FORGAC 2008; JEFFERIES et al. 2008) .
Cellular regulation of pH plays at least two critical roles in influenza viral infection. When the influenza virus is imported into the cell within an endocytic vesicle, V 1 V 0 ATPase pumps are situated in the vesicle membrane such that they pump protons inside the vesicle ( VAN DYKE 1996) . This increased pH allows for M2 activation, and M2 transports protons into the interior of the virion (PALESE and SHAW 2007) . Inhibition of the V 1 V 0 ATPase pump in the late endosome, preventing acidification, would likely inhibit M2 activation and thus inhibit viral uncoating. In fact this has been shown to be true (GUINEA and CARRASCO 1995; OCHIAI et al. 1995; PEREZ and CARRASCO 1994) . On the other hand, overexpression of the V 1 V 0 ATPase pump at this stage of influenza viral infection might alter the V 1 V 0 ATPase assembly, and perhaps increase the ability of M2
to acidify the interior of the virion to cause increased viral uncoating and replication. Our findings support these hypotheses ( Fig. 7 and 8 ). Other work lends supports to our data.
In an RNAi screen in an influenza virus-infectable Drosophila S2 cell line, two subunits of the V 1 V 0 ATPase (Drosophila vhaAC39 and vha16, which are homologous to V 0 D1
and V 0 C, respectively) were shown to be essential for influenza viral replication (HAO et al. 2008) . Curiously no other V 1 V 0 ATPase subunits were identified in this screen, suggesting that either the genes were essential for cell viability (and thus their knock down resulted in cell death) or that the RNAi system failed to knock down expression low enough to produce an influenza virus replication defect. Given the non-epithelial nature of S2 cells, it is possible that other mechanisms, such as the organization of the cytoskeleton or apical/basal polarity, differentiate requirements for influenza viral replication in a non-epithelial versus epithelial cell types. More recently, an RNAi screen in human lung epithelial cells identified several human genes necessary for influenza viral replication (KONIG et al. 2010) . In relation to our work, the V 1 V 0 ATPase subunits V 1 A, V 1 B, V 0 B, and V 0 C were identified as essential (KONIG et al. 2010) . It is interesting to note that two of the four subunits that Konig et al found to be important correspond to two of the three subunits that we determined to be important for M2 activity and influenza virus replication.
In addition to the obvious utility of identifying novel genetic modifiers of M2
proton channel activity for the study of viral and host cell interactions, we believe that our M2 "Flu Fly" system can play an important role in the identification of two types of new anti-influenza virus compounds: (1) new inhibitors of the M2 proton pump, and (2) compounds that modulate endogenous V 1 V 0 ATPase activity (or other M2-activity essential mechanisms). As we have shown with amantadine, compounds can be added to fly food, fed to M2-expressing larvae (perhaps using a lethal expression system), and the compounds that had been fed to flies that survived then tested for their abilities to inhibit M2 activity and viral replication in mammalian cell culture.
The modifiers that we have identified (Table 3) In summary, we have established a transgenic model system to study influenza virus M2 protein activity. We have shown that the Drosophila system is an excellent heterologous system to study a viral protein that alters intracellular physiology. We have shown that the M2 protein functions and localizes properly within Drosophila cells and we have used this system to identify important host genes that impact the ability of M2 to alter intracellular pH.
The M2 "Flu Fly" has proven to be an efficient means of identifying cellular genes which impact influenza viral replication. This model system can also be used to develop and test novel drugs for anti-viral therapy. Our results suggest that the Drosophila "Flu Fly" system would also benefit by expansion to include other influenza virus genes, with the goal of identifying additional cellular proteins that might become anti-viral drug targets.
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